Welcome to Porsolt, a long established preclinical CRO providing in vitro, in ovo, in vivo, and ex vivo services for screening, efficacy, and safety profiling of test substances, together with bioanalytical and histology capabilities
Porsolt has a long standing international reputation for expertise in physio-pathological models, customized procedures, and tailored solutions for discovering treatments in multiple disease areas, including psychiatric and neurological disorders, oncology, acute and chronic pain, inflammation, cardiac and vascular diseases, metabolic and eating disorders, dermatology, and medical devices, using in vitro cell lines and in vivo disease models in multiple species. Porsolt also provides GLP safety evaluation of drug candidates from screening to regulatory studies before first-in-man administration, including predictive toxicology, full assessment of cardiac risk, and abuse and dependence liability. Our tissue preparaton, histology capabilities, staining and image analysis, also allow for a complete service, including bioanalytical services.